C07D 223/14
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D223/14 (Condensed with carbocyclic rings or ring systems) appears on 1,085 US grants and 890 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,085
- Published applications
- 890
- Assignees
- 532
- Inventors
- 2,913
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 18 | 0 |
| 1977 | 17 | 0 |
| 1978 | 18 | 0 |
| 1979 | 14 | 0 |
| 1980 | 16 | 0 |
| 1981 | 15 | 0 |
| 1982 | 18 | 0 |
| 1983 | 10 | 0 |
| 1984 | 18 | 0 |
| 1985 | 13 | 0 |
| 1986 | 10 | 0 |
| 1987 | 12 | 0 |
| 1988 | 15 | 0 |
| 1989 | 11 | 0 |
| 1990 | 14 | 0 |
| 1991 | 21 | 0 |
| 1992 | 11 | 0 |
| 1993 | 23 | 0 |
| 1994 | 18 | 0 |
| 1995 | 19 | 0 |
| 1996 | 27 | 0 |
| 1997 | 35 | 0 |
| 1998 | 35 | 0 |
| 1999 | 20 | 0 |
| 2000 | 18 | 0 |
| 2001 | 16 | 3 |
| 2002 | 19 | 34 |
| 2003 | 28 | 34 |
| 2004 | 18 | 49 |
| 2005 | 17 | 51 |
| 2006 | 31 | 46 |
| 2007 | 29 | 61 |
| 2008 | 30 | 50 |
| 2009 | 18 | 50 |
| 2010 | 28 | 51 |
| 2011 | 30 | 29 |
| 2012 | 42 | 36 |
| 2013 | 37 | 43 |
| 2014 | 33 | 44 |
| 2015 | 44 | 40 |
| 2016 | 32 | 38 |
| 2017 | 35 | 34 |
| 2018 | 14 | 26 |
| 2019 | 40 | 32 |
| 2020 | 19 | 23 |
| 2021 | 14 | 18 |
| 2022 | 12 | 23 |
| 2023 | 9 | 29 |
| 2024 | 9 | 19 |
| 2025 | 17 | 18 |
| 2026 | 18 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Benzoazepine compound, and composition and use thereof15 Sep 2026US 12,735,398 B2Shanghaitech University
- Benzonitric heterocyclic compound, preparation method therefor and use thereof18 Aug 2026US 12,709,600 B2Shanghai Institute of Pharmaceutical Industry
- Tetrahydroisoquinoline compound as potassium channel modulator and preparation and application thereof11 Aug 2026US 12,703,687 B2Shanghai Zhimeng Biopharma, Inc.
- Compounds, compositions, and methods for isolation of nucleic acids30 Jun 2026US 12,668,577 B2Ptomega Corporation
- Organic electroluminescent element and electronic device using same30 Jun 2026US 12,668,739 B2Idemitsu Kosan Co., Ltd.
- Novel compounds with mtorc2-inhibitory activity and uses thereof10 Sep 2026US 2026/0265267 A1Aliad Biopharma
- Heterocyclic compounds as selective hdac6 inhibitors20 Aug 2026US 2026/0242358 A1Miralinc Pharma, Inc.
- Dibenzodiazepines derivatives, pharmaceutical compositions and uses2 Jul 2026US 2026/0184731 A1Shenzhen Evergreen Therapeutics Co., Ltd.
- Methods and materials for increasing level of phosphorylated ampk protein21 May 2026US 2026/0138955 A1University of Pittsburgh—Of the Commonwealth System of Higher Education
- Urolithin derivatives and methods of use thereof14 May 2026US 2026/0132117 A1Vandria SA
Most cited
By later US patents
- Pharmaceutical formulations for parenteral use208US 5,024,998 AUniversity of Florida · 1991
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009
- Condensed heterocyclic compounds154US 5,037,825 AHoffmann-La Roche Inc. · 1991
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Azlactone-related dopants in the emissive layer of an OLED141US 6,030,715 AThe Trustees of Princeton University · 2000